FASLODEX may be an option for you
FASLODEX is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women whose disease
has spread after treatment with antiestrogen medicine, such as tamoxifen.
If you have been diagnosed with hormone receptor-positive metastatic breast
your doctor may have discussed
hormonal therapy. Antiestrogen therapy is a type of hormonal therapy that treats breast cancers that depend on estrogen for growth. FASLODEX is an antiestrogen therapy.
If you are postmenopausal and your hormone receptor-positive metastatic breast cancer has
spread following treatment with an antiestrogen medicine, your doctor may decide to try FASLODEX.
Estrogen receptors are found in and on breast cells. Estrogen binds to estrogen
receptors, like a key fitting into a lock. This can activate the receptor and cause
hormone receptor-positive tumors to grow. FASLODEX binds to and blocks estrogen receptors
and reduces the number of estrogen receptors in breast cells.
For over a decade, doctors have relied on FASLODEX to help slow the growth of metastatic
breast tumors that are fueled by estrogen. It is prescribed to treat postmenopausal
women with hormone receptor-positive metastatic breast cancer whose disease has spread after treatment
with antiestrogen medicine.
Talk to your doctor about FASLODEX